Suppr超能文献

坦桑尼亚恶性疟原虫裂殖子表面蛋白2的基因型

Genotypes of merozoite surface protein 2 of Plasmodium falciparum in Tanzania.

作者信息

Felger I, Irion A, Steiger S, Beck H P

机构信息

Swiss Tropical Institute, Basel, Switzerland.

出版信息

Trans R Soc Trop Med Hyg. 1999 Feb;93 Suppl 1:3-9. doi: 10.1016/s0035-9203(99)90320-6.

Abstract

The merozoite surface protein 2 (MSP2) of Plasmodium falciparum is extremely polymorphic: 82 different msp2 alleles were found in 4 studies of molecular epidemiology conducted in Tanzania. This diversity renders msp2 suitable as a marker gene for the genotyping of P. falciparum infections. Amplification of msp2 by the polymerase chain reaction (PCR), and subsequent restriction digests of the PCR product (PCR-restriction fragment length polymorphism genotyping), has proved to be an informative tool for enumerating multiple concurrent infections in a blood sample, and distinguishing individual alleles. Depending on the specific questions asked in a genotyping study, analytical techniques of different degrees of complexity are employed. The restriction fragments resulting from a single HinfI digest generally allow the enumeration of multiple concurrent infections and the determination of their allelic families. When a restriction pattern is too complex to be resolved, owing to the high number of concurrent infections, or due to the appearance of previously undescribed alleles, one or more additional digests (DdeI, RsaI, ScrfI) may be necessary. To determine individual alleles unequivocally, in particular in longitudinal studies, when several consecutive samples need to be compared with each other, a more detailed analysis involving all 3 additional digests is applied. The methodological experience and results gained in 4 epidemiological field studies involving msp2 genotyping are summarized. We also provide the HinfI restriction patterns and some nucleotide sequences of the alleles found so far in our studies in Tanzania.

摘要

恶性疟原虫的裂殖子表面蛋白2(MSP2)具有高度多态性:在坦桑尼亚进行的4项分子流行病学研究中发现了82种不同的msp2等位基因。这种多样性使msp2适合作为恶性疟原虫感染基因分型的标记基因。通过聚合酶链反应(PCR)扩增msp2,并对PCR产物进行后续限制性酶切(PCR-限制性片段长度多态性基因分型),已被证明是一种用于确定血液样本中多种同时感染情况以及区分个体等位基因的有用工具。根据基因分型研究中提出的具体问题,会采用不同复杂程度的分析技术。单次HinfI酶切产生的限制性片段通常可用于确定多种同时感染情况及其等位基因家族。当由于同时感染数量过多或出现以前未描述的等位基因而导致限制性图谱过于复杂难以解析时,可能需要进行一次或多次额外的酶切(DdeI、RsaI、ScrfI)。为了明确确定个体等位基因,特别是在纵向研究中,当需要相互比较几个连续样本时,会应用涉及所有3种额外酶切的更详细分析。总结了在4项涉及msp2基因分型的流行病学现场研究中获得的方法学经验和结果。我们还提供了在坦桑尼亚的研究中迄今发现的等位基因的HinfI限制性图谱和一些核苷酸序列。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验